이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Feasibility of a 4-Week Intensive Postoperative Multimodal Rehabilitation Program in Complicated Patients After Proximal Pancreatectomy: A Prospective Single-Cohort Study (REACT)

2026년 8월 14일 업데이트: Nicolò Pecorelli, IRCCS San Raffaele

The REACT study is a prospective, single-center, single-cohort study designed to evaluate the feasibility of a 4-week intensive multimodal postoperative rehabilitation program in patients who develop severe complications after proximal pancreatic resection (pancreatoduodenectomy or total pancreatectomy).

Postoperative complications after pancreatic surgery may result in substantial physiological and metabolic stress, leading to loss of muscle mass, malnutrition, reduced functional capacity, and delayed recovery. Although prehabilitation programs have been proposed to improve patients' functional capacity before surgery, evidence regarding structured multimodal rehabilitation after pancreatic surgery is currently lacking.

Adult patients undergoing elective proximal pancreatic resection who develop a severe postoperative complication (Comprehensive Complication Index >21) will be eligible for the study. Participants will undergo a 4-week multimodal rehabilitation program starting after hospital discharge and including individualized exercise training, nutritional therapy, and anxiety-reducing techniques. The program may be delivered either in a supervised hospital-based setting or through a home-based program according to patient preference and availability.

The primary objective is to assess the feasibility of the rehabilitation program in terms of recruitment, adherence, completion of outcome assessments, completeness of data, and safety. Secondary objectives include evaluating postoperative functional recovery using PROMIS-29 Physical and Mental Health Summary Scores, the 6-minute walk test, and the Duke Activity Status Index. In patients with malignancy who are candidates for adjuvant treatment, return to intended oncologic treatment will also be evaluated.

A total of 40 patients will be enrolled and followed for up to 90 days after surgery.

연구 개요

상태

아직 모집하지 않음

정황

개입 / 치료

상세 설명

Pancreatic surgery is associated with a high rate of postoperative morbidity. Postoperative complications may impose substantial physiological and metabolic stress, leading to depletion of functional reserves, loss of muscle mass and energy stores, malnutrition, sarcopenia, and reduced functional capacity. Recovery may be particularly prolonged in patients experiencing severe postoperative complications and in frail patients with limited physiological and metabolic reserves. Although multimodal prehabilitation has been proposed to improve functional capacity before major surgery, evidence supporting the role of structured multimodal rehabilitation in improving recovery after pancreatic resection is currently lacking.

REACT is a prospective, single-center, single-cohort, low-interventional clinical study conducted at IRCCS Ospedale San Raffaele, Milan, Italy. The study is designed to evaluate the feasibility of a 4-week intensive multimodal postoperative rehabilitation program in patients who develop severe complications after proximal pancreatic resection. All enrolled participants will receive the multimodal rehabilitation intervention in addition to standard postoperative care; no formal comparator group is included.

The study population will include adult patients undergoing elective proximal pancreatic resection, defined as pancreatoduodenectomy or total pancreatectomy, who develop a severe postoperative complication during their hospital stay, defined according to a Comprehensive Complication Index (CCI) >21.

The multimodal rehabilitation program will start during the first week after postoperative hospital discharge and will last 4 weeks. The intervention includes exercise training, nutritional therapy, and anxiety-reducing techniques and will be individualized according to the patient's physical, nutritional, psychological, and clinical condition. Activities will be performed under the supervision of qualified healthcare professionals, including physiotherapists, nutritionists, and psychology-trained personnel.

The exercise component will include endurance, resistance, and breathing exercises tailored to the individual patient's clinical condition. Endurance training will consist of progressively increasing moderate-intensity continuous training, with intensity adjusted according to patient performance and perceived exertion using the Borg scale. Resistance exercises will involve different upper- and lower-limb muscle groups, with progressive workload adjustments based on individual performance. The program will include two to three supervised training sessions per week, with a minimum frequency of three exercise sessions per week specified for the overall program.

Exercise rehabilitation may be delivered either in a hospital-based or home-based setting according to patient preference and availability. Hospital-based exercise sessions will be conducted in the hospital gym. For patients following the home-based program, the hospital-based intervention will be adapted while maintaining the same overall duration, therapeutic goals, and monitoring approach. Outdoor walking may replace treadmill- or cycle-based aerobic exercise when equipment is unavailable, while resistance exercises will be performed using resistance bands provided by the study center. Educational materials, video demonstrations, and monitoring devices will be provided when appropriate.

The nutritional component will consist of an individualized dietary management plan based on dietary habits, medical conditions, and nutritional status. A balanced food-based intervention will be prescribed to meet estimated caloric and nutritional requirements. A daily protein intake of 1.5-2.0 g/kg of ideal body weight will be recommended, and whey protein supplementation may be prescribed when needed. Participants will also receive instruction on anxiety-reducing strategies, including imagery, visualization, and deep-breathing techniques.

The primary objective of the study is to assess the feasibility of the 4-week multimodal rehabilitation program. Feasibility will be evaluated according to five predefined criteria: at least 50% of eligible patients agree to participate; at least 80% of enrolled patients adhere to the program; at least 80% of participants complete an outcome assessment after rehabilitation; the proportion of missing data among patients completing outcome assessments is below 10%; and no serious adverse events related to the rehabilitation program occur. The intervention will be considered feasible only if all five predefined criteria are met.

Adherence will be defined as completion of at least 80% of the planned intervention components, including exercise sessions, nutritional consultations, and psychological support sessions. For hospital-based rehabilitation, adherence will be documented by the rehabilitation team, while adherence to the home-based program will be assessed using patient diaries reviewed during regular telephone contacts. An exploratory subgroup analysis will compare feasibility outcomes between hospital-based and home-based rehabilitation.

Secondary objectives will evaluate functional recovery following surgery. Outcomes will include the Patient-Reported Outcomes Measurement Information System-29 (PROMIS-29) Physical Health Summary Score and Mental Health Summary Score, the 6-minute walk test (6MWT), and the Duke Activity Status Index (DASI). Recovery will be assessed in relation to preoperative values and predefined minimal important differences. Assessments will be performed preoperatively, at hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery. In patients with malignancy who are candidates for adjuvant treatment, time to return to intended oncologic treatment (RIOT) will also be evaluated.

Safety will be assessed by monitoring, recording, and analyzing adverse events occurring during the study, with particular attention to events potentially related to exercise training, nutritional intervention, or psychological support. Routine clinical assessments performed as part of standard postoperative care will also contribute to the safety evaluation.

The planned sample size is 40 participants. Assuming an expected adherence rate of 80%, this sample size allows adherence to be estimated with a 95% confidence interval of approximately ±12 percentage points and is considered appropriate for the pilot feasibility objective of the study. Enrollment is planned over 12 months, the rehabilitation intervention will last 4 weeks, and participants will be followed for up to 3 months.

연구 유형

중재적

등록 (추정된)

40

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 성인
  • 고령자

건강한 자원 봉사자를 받아들입니다

아니

설명

  • Inclusion Criteria:
  • Age ≥18 years.
  • Patients undergoing elective proximal pancreatic resection (pancreatoduodenectomy or total pancreatectomy).
  • Patients developing a severe postoperative complication during their hospital stay, defined as a Comprehensive Complication Index (CCI) >21.
  • Exclusion Criteria:
  • Metastatic disease.
  • Surgical procedures other than pancreatoduodenectomy or total pancreatectomy.
  • Inability to speak Italian.
  • Cognitive impairment or illiteracy resulting in inability to read and understand the Italian language.
  • Medical conditions contraindicating the rehabilitation regimen (exercise and nutritional intervention), including orthopedic or cognitive disabilities and chronic renal failure (dialysis or creatinine >250 mmol).
  • Pregnancy.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 해당 없음
  • 중재 모델: 단일 그룹 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Multimodal Postoperative Rehabilitation
Participants will receive a 4-week intensive multimodal postoperative rehabilitation program starting during the first week after hospital discharge. The program includes individualized exercise training, nutritional therapy, and anxiety-reducing techniques, tailored to each participant's clinical, physical, nutritional, and psychological condition. Exercise training will be delivered either in a supervised hospital-based setting or through a home-based program according to patient preference and availability. All participants will receive the multimodal rehabilitation program in addition to standard care
Participants will undergo a 4-week multimodal postoperative rehabilitation program starting during the first week after hospital discharge. The program includes individualized exercise training, nutritional therapy, and anxiety-reducing techniques. Exercise includes moderate-intensity endurance, resistance, and breathing exercises tailored to the patient's clinical condition and may be delivered in a hospital-based or home-based setting. Nutritional therapy consists of an individualized dietary plan, with a recommended protein intake of 1.5-2.0 g/kg of ideal body weight and whey protein supplementation if needed. Participants will also receive instruction in relaxation techniques, including imagery, visualization, and deep-breathing exercises. The program is delivered by qualified physiotherapists, nutritionists, and psychology-trained personnel.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Feasibility of the multimodal postoperative rehabilitation program
기간: At the end of the 4-week rehabilitation program

Feasibility will be assessed according to five predefined criteria:

  1. ≥50% of eligible patients agree to participate;
  2. ≥80% of enrolled patients adhere to the program;
  3. ≥80% complete the post-rehabilitation outcome assessment;
  4. missing data among patients completing outcome assessments are <10%; (5) no serious adverse events related to the rehabilitation program occur.

The intervention will be considered feasible only if all five criteria are met.

At the end of the 4-week rehabilitation program

2차 결과 측정

결과 측정
측정값 설명
기간
PROMIS-29 Physical Health Summary Score recovery
기간: At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Proportion of participants who recover their preoperative PROMIS-29 Physical Health Summary Score (PHS) or show a decline smaller than the minimal important difference (MID) of 2.3 points.
At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
PROMIS-29 Mental Health Summary Score recovery
기간: At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Proportion of participants who recover their preoperative PROMIS-29 Mental Health Summary Score (MHS) or show a decline smaller than the minimal important difference (MID) of 2.3 points.
At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Six-Minute Walk Test recovery
기간: At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Proportion of participants who recover their preoperative 6-minute walk test (6MWT) performance or show a decline smaller than the minimal important difference of 19 meters.
At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Duke Activity Status Index recovery
기간: At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Proportion of participants who recover their preoperative Duke Activity Status Index (DASI) or show a decline smaller than the minimal important difference of 6 METs.
At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 9월 1일

기본 완료 (추정된)

2027년 3월 31일

연구 완료 (추정된)

2028년 3월 31일

연구 등록 날짜

최초 제출

2026년 8월 11일

QC 기준을 충족하는 최초 제출

2026년 8월 14일

처음 게시됨 (실제)

2026년 8월 17일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 8월 17일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 8월 14일

마지막으로 확인됨

2026년 8월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • REACT

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

미정

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .